Àgata Gelabertó (co-Founder and Chief Executive Officer)
Mrs. A. Gelabertó received a Master of Science in Chemical Engineering from the Institut Quimic de Sarria and a Master in Business Administration from ESADE Business School.
Expert in Business Innovation, Agata’s is an experienced businesswomen, developing her career within the Sales, R&D, and Marketing divisions of Avebe and Danone. For the past eight years Agata has lead the creation of new brands and new business development for Danone. Agata is currently responsible for Danone’s Retail Business unit in Spain.
Agata and her husband, Mr. A. Milé have a daughter named Andrea who was born in 2004 with microtia. This was the starting point for Agata and Albert’s interest in improving current techniques for microtia repair with the best possible alternative: cartilage regeneration.
Albert Milé (co-Founder and Financial Vice President)
Mr. A. Milé received a Chemical Engineering Degree from Institut Quimic de Sarria and a Master in Business Management from ESADE Business School.
Albert has extensive experience working as Director of Operations, Sales Director, and General Manager in several multinational companies including Bachiller, Aggreko, and EJ. Brooks.
Mercedes Balcells, Ph.D. (co-Founder and Research and Development Vice President)
Dr. Balcells received a Masters of Science degree in Chemical Engineering from Institut Químic de Sarrià and in Chemistry from Ramon Llull University, and a PhD in Macromolecular Chemistry from RWTH Aachen as a fellow from the German Academic Exchange Services (DAAD) and La Caixa. She was awarded the Borchers Prize to the best PhD thesis in her discipline.
Dr. Balcells is a senior Research Scientist at the Harvard-MIT Division of Health Sciences and Technology, directs the MIT-Spain Program and is a Professor in Bioengineering at Institut Químic de Sarrià (Universitat Ramon Llull, Barcelona).
Dr. Balcells’ research focuses in the study of the combined effects of complex flow alterations and local molecular interventions on cellular injury and repair. She has pioneered the use of bioreactors to expose cells to physiological relevant environments in vitro. Her studies have led to 16 original publications and 25 abstracts in high impact international journals and conferences. Dr. Balcells was a nominee to the 2010 MIT Excellence Awards.
Elazer Edelman, M.D., Ph.D., F.A.C.C. (co-Founder)
Bachelor of Science degrees in Bioelectrical Engineering and in Applied Biology from MIT, a Masters of Science degree in Electrical Engineering and Computer Sciences from MIT, a degree in medicine from Harvard Medical School and a Ph.D. in Medical Engineering and Medical Physics from MIT.
Dr. Edelman is the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at MIT, Professor of Medicine at Harvard Medical School, and a coronary care unit cardiologist at the Brigham and Women’s Hospital in Boston. Dr. Edelman also directs the Harvard-MIT Biomedical Engineering Center (BMEC), dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease.
Dr. Edelman is a fellow of, the American College of Cardiology, the American Heart Association, the American Institute for Medical and Biological Engineering, and the American Society for Clinical Investigation. In 2010, Prof. Edelman has been awarded the Cross of the Order of Civil Merit by the Spanish government for his significant contribution to the progress of science and education in the country.
Dr. Edelman and his laboratory have pioneered basic findings in vascular biology. Work with antisense oligonucleotides, HDL receptor biology and tissue engineered endothelial implants are a few examples of novel directions taken by his laboratory that has produced more than 250 top-ranked publications and proceedings in top ranked journals and 32 patent applications. Many of his findings are now in clinical trial validation.